Authors
Latest:
Advice for Clinicians Managing AsthmaThe panel offers their final recommendations for physicians managing patients with asthma.
Latest:
The Future of Geographic Atrophy TreatmentVeeral Sheth, MD, MBA discusses the 3 improvements needed for the future of treating patients with geographic atrophy.
Latest:
Communication With Patients With VitiligoIltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Latest:
The Future of oHCM TreatmentAndrew Wang, MD; James Januzzi, MD; Michelle M. Kittleson, MD, PhD; and Milind Desai, MD, MBA, share a look into the future of oHCM treatment.
Latest:
Moving Beyond the Joint: The Interplay Between Gout and Kidney DiseaseNehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.
Latest:
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across USBirgit Vogel, MD discusses racial inequities and geographic variations in peripheral artery disease care in the United States.
Latest:
Selecting CD Treatment in Special ScenariosExperts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.
Latest:
Practice Pearls for the Management of Atopic DermatitisAlexa Hetzel, MA, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, PA, share practice pearls and clinical management tips for the care of pediatric patients with atopic dermatitis.
Latest:
Advice for Managing Patients With PNShawn Kwatra, MD, and Sarina B. Elmariah, MD, PhD, share final pearls of wisdom for other physicians taking care of patients with prurigo nodularis (PN).
Latest:
A Year of RSV Highs and Lows, with Tina Tan, MDThe Contemporary Pediatrics Editor-in-Chief reviews the pharmacological breakthroughs and epidemiological setbacks that defined RSV in 2023.
Latest:
Novel Agents for the Management of Pediatric and Adult ADHDDrs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Latest:
Novel Investigational Approaches For the Treatment of Neovascular AMDDr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Latest:
Future Landscape of BTK Inhibitors for CSUPanelists discuss the current and future roles of advanced treatments, including biologics and Bruton tyrosine kinase (BTK) inhibitors, in the management of chronic spontaneous urticaria (CSU), highlighting their potential to improve patient outcomes and the evolving landscape of treatment options.
Latest:
Diabetes Dialogue: News and Updates in Diabetes at AHA 2024In this episode, hosts break down a pair of studies from AHA 2024, BPROAD and SUMMIT, as well as a study in JAMA projecting semaglutide eligibility in US adults.
Latest:
Efficacy of Prescription Vs OTC Fish Oil ProductsWhat pharmacists and providers need to know to counsel patients on when discussing the use of prescription or over-the-counter fish oil supplement as treatment for dyslipidemia and hypertriglyceridemia.
Latest:
Importance of Long-Term Data in Plaque PsoriasisLeon Kircik, MD, shares his impressions of the long-term data of roflumilast, and where it fits into clinical practice.
Latest:
Approaching Plaque Psoriasis Treatment in Difficult-to-Treat AreasAn expert in dermatology provides insight on approaching treatment in patients with plaque psoriasis who have a low BSA involvement, but with symptoms that present in difficult-to-treat areas.
Latest:
Emerging Agents for Heart Failure TreatmentJames Januzzi, MD, and Javed Butler, MD, MPH, MBA, discuss emerging agents, vericiguat and intravenous (IV) iron, in the treatment landscape for heart failure with reduced ejection fraction and advice for community physicians managing patients with heart failure.
Latest:
Steroids and Immunosuppressive Agents for CSUPanelists discuss how steroids can play a role in the management of chronic spontaneous urticaria (CSU), while emphasizing that practitioners should exercise caution due to potential adverse effects and the need for careful monitoring when using systemic steroids.
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Latest:
Will Tirzepatide Finally Turn the Tide in Access to Obesity Treatment?In this column, Katherine Saunders, MD, of Weill Cornell Medicine, provides perspective on the approval of tirzepatide for chronic weight management and what it might mean for patient access in the future.
Latest:
Current Barriers to uACR TestingPanelists discuss the current barriers to urine albumin-creatinine ratio (uACR) testing, strategies to address these barriers, the guideline goals for reducing uACR, and the importance of a multimodal approach, as well as how increased awareness of chronic kidney disease (CKD) testing can improve patient outcomes and engage health care providers in promoting testing.
Latest:
Bariatric Surgery is Associated with Reduced Risk of Pancreatic Cancer: Analysis of a US National DatabaseA history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
Addressing Vaccine Hesitancy and Uptake for SARS-CoV-2Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, and Madeline King, PharmD, BCIDP, provide insight on vaccine hesitancy among patients and the importance of increasing vaccine uptake to protect against SARS-CoV-2.
